PERT CONSORTIUM 7th Symposium Annual Pulmonary Embolism 2021

Regular price
$10.00
Sale price
$10.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

PERT CONSORTIUM 7th Symposium Annual Pulmonary Embolism 2021

Format:61 videos, size: 18.1 GB

Course Audience: practicing clinicians who diagnose and/or treat patients with pulmonary embolism

Overview:

The PERT Consortium was formed to promote best practices in Pulmonary Embolism (PE) care. By focusing solely on the entirety of PE – its etiology, pathophysiology, prevention, management approach, outcomes of specific treatments, and follow-up pathways – it is the intention of the Consortium to increase awareness of treatment options available to patients with PE, to reduce its incidence worldwide, to improve health outcomes, and to positively influence the impact of this terrible disease.

This annual 2 day, AMA PRA/ANCC‐accredited conference entitled, ”Pulmonary Embolism: What is Known, and What We Need to Know: A State of the Art and Scientific Update”, is designed for practicing clinicians who regularly care for patients with acute and chronic pulmonary embolism (PE), as well as those who are interested in studying the pathophysiology, epidemiology, diagnosis, prevention, medical and interventional management, novel treatment paradigms, and outcomes of pulmonary embolism (PE). The meeting agenda has been expanded to include topics and presentations surrounding COVID-19 and the unique association of this virus with Venous Thromboembolic Disease (VTE), and specifically its impact on incidence, diagnosis and unique management strategies of Pulmonary Embolism.

The annual PERT business meeting will take place on October 14th.

This two day course is designed to educate practicing clinicians who diagnose and/or treat patients with pulmonary embolism; academics and scientists who study pulmonary embolism.

Learning Objectives

At the conclusion of this activity, the participants will be able to:

  • Discuss the epidemiology and pathophysiology of PE, including how to assess the risk of patients presenting with symptoms consistent with PE.
  • Identify features that define low, intermediate and high‐risk PE
  • Develop a diagnostic and treatment algorithm that incorporates risk stratification and meets the specific needs of patients presenting with signs and symptoms of PE.
  • Appropriately select among various treatment options for intermediate‐ and high‐risk PE patients including: anticoagulation, fibrinolysis (intravenous and catheter‐directed), extra‐corporeal membrane oxygenation (ECMO), thrombectomy (suction and surgical), and IVC filter placement.
  • Recognize the potential acute complications of PE and how to prevent and treat them.
  • Develop algorithm to identify and manage long term consequences of PE, such as CTEPH and CTED; understand combination of pharmacologic and mechanical treatment options available for use in such patients.
  • Describe unique patient populations with PE and their specific treatment challenges
  • Discuss the benefits of a multidisciplinary approach to PE management, and how to implement a PE Response Team (PERT) in their hospital.
  • Identify what constitutes high quality care for PE.
  • Target opportunities for quality improvement at an institutional level.
  • Address thrombosis issues related to COVID-19, specifically:
  • Delineate the risk of thrombosis associated with COVID-19 infection
  • Characterize the various manifestations and presentations of thrombosis and VTE seen with COVID-19, including the VITT syndrome
  • Identify the proper testing pathways for COVID-19 associated clotting disorders
  • Specify anticoagulation regimens currently utilized to treat active thrombosis, as well as the range of therapeutics available as prophylaxis to prevent recurrence in hospitalized patients.
  • Delineate proper anticoagulation strategies for hospitalized COVID-19 patients
  • Define proper anticoagulation for outpatients with active or convalescent infection
  • Prescribe appropriate treatment/prophylaxis after discharge of COVID-19 patients
  • Define the value and benefits of the multi-disciplinary approach in the management of PE and VTE, including the PERT approach
  • Establish the role of PERT in COVID-19 patient, including adjustments in the treatment paradigms necessitated by active infection

Acute PE Management Cardiopulmonary Bypass Technique to Support Percutaneous Treatment (Video MP4 Format)

Acute Pulmonary Embolism Clinical Evaluation and Biochemical Markers (Video MP4 Format)

Artificial Intelligence and Acute Pulmonary Embolism (Video MP4 Format)

Balloon Pulmonary Angioplasty for CTEPH PERT 2021 (Video MP4 Format)

Bleeding Management and Use of Anticoagulants Panel Discussion (Video MP4 Format)

Bleeding Management Beyond Reversal (Video MP4 Format)

Bleeding Under UFH LMWH Fibrinolytics (Video MP4 Format)

COVID-19 Thromboprophylaxis and Treatment (Video MP4 Format)

Creating PERT Teams Workshop (Video MP4 Format)

CT Imaging Predictors of Oxygen Requirement at Discharge in Submassive Pulmonary Embolism (Video MP4 Format)

CTED vs CTEPH vs PTSD Unraveling the Gordian Knot (Video MP4 Format)

Diagnosis and Risk Stratification in PE Recent Guidelines and Impactful Papers (Video MP4 Format)

DOAC for Extended Duration Anticoagulation (Video MP4 Format)

DOAC-Associated Bleeding Management (Video MP4 Format)

ECHO and the Danger of Right Ventricle (Video MP4 Format)

ECMO and PE Indications, Contraindications, and Surgery (Video MP4 Format)

ECMO Cannulation for Acute Pulmonary Embolism (Video MP4 Format)

ECMO in PE Management and Ethics (Video MP4 Format)

Epidemiology of COVID-19 and Related Thrombosis (Video MP4 Format)

Global Impact of PE and Differences Between the US, Europe, Africa, and Asia (Video MP4 Format)

High Risk (Massive) Pulmonary Embolism Use of Systemic Thrombolysis and Mechanical Circulatory Support (Video MP4 Format)

Imaging Updates for Pulmonary Embolism Diagnosis CTA, MRA, Novel Contrast Agents and Spectral CT (Video MP4 Format)

Innovations in PE Management What Are the New Devices (Video MP4 Format)

Interventions for PE in 2021 Papers You Need to Know (Video MP4 Format)

IVC Filters Indications for the Use and Strategies for Their Removal (Video MP4 Format)

Management of Patients With Intermediate-Risk PE (Video MP4 Format)

Management of Patients With Low-Risk PE (Video MP4 Format)

Management of PE in 2021 How Early Can You Switch Patients With Acute Intermediate-Risk PE to Oral Anticoagulation (Video MP4 Format)

Management of PH With Medical Therapy, Balloon Angioplasty and Pulmonary Thromboendarterectomy Panel Discussion (Video MP4 Format)

Management of Tumor Thrombi (Video MP4 Format)

Mechanical Circulatory Support in Acute Pulmonary Embolism Device Options (Video MP4 Format)

Mechanical Circulatory Support in PE Workshop (Video MP4 Format)

New European Guidelines on Pulmonary Embolism What Has Changed and Why (Video MP4 Format)

Pathobiology and Medical Management of CTEPH Panel Discussion (Video MP4 Format)

Pathobiology of CTEPH What Are the Factors That Contribute to CTEPH (Video MP4 Format)

PE Diagnosis Panel Discussion (Video MP4 Format)

PE in the Ambulatory and Hospital Settings Scope of the Problem (Video MP4 Format)

PE-Tract Trial CDT or AC for Patients With Submassive PE (Video MP4 Format)

Pharmacotherapy in CTEPH Patients (Video MP4 Format)

POCUS in Pulmonary Embolism (Video MP4 Format)

Post PE Management Panel Discussion (Video MP4 Format)

Prevention of Cancer-Associated Thrombosis (Video MP4 Format)

Pulmonary Thromboendarterectomy for Chronic Pulmonary Thromboembolic Disease (Video MP4 Format)

Regulatory Pathways for Devices for Management of Pulmonary Embolism FDA Perspectives (Video MP4 Format)

Regulatory Pathways for PE Management Panel Discussion (Video MP4 Format)

Right Ventricular Failure and Pulmonary Infarction (Video MP4 Format)

Simultaneous Real-Time Intravascular Ultrasound Guided Transcatheter Pulmonary Embolectomy Improves Procedural Accuracy, Efficacy and Safety (Video MP4 Format)

STRIKE-PE Study Safety and Performance of the Aspiration System for the Treatment of Pulmonary Embolism (Video MP4 Format)

Survivorship After PE What to Follow and How to Follow Our Patients (Video MP4 Format)

The Clive Kearon Memorial Lecture (Video MP4 Format)

The FLAME Trial Mechanical Thrombectomy for Acute Massive Pulmonary Embolism (Video MP4 Format)

The Higher-Risk Pulmonary Embolism Thrombolysis Study (HI-PEITHO) Catheter-Directed Thrombolysis Vs Anticoagulation (Video MP4 Format)

The Regulatory Environment Affect on PE Patient Care Practicing Clinical’s Perspective (Video MP4 Format)

Thrombosis Management in COVID-19 Patients Panel Discussion (Video MP4 Format)

Trends and Outcomes of Acute Pulmonary Embolism Transfers A Nationwide Cohort Sample 2008-2018 (Video MP4 Format)

Triaging Acute Pulmonary Embolism for Home Treatment or Simplified PESI Criteria The HOME-PE Randomized Trial (Video MP4 Format)

Updates on PERT Consortium Registry (Video MP4 Format)

Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) (Video MP4 Format)

VTE Prevention in Medical Patients (Video MP4 Format)

VTE Prevention in the Surgical Patient (Video MP4 Format)

VTE Prevention Panel Discussion (Video MP4 Format)

Go to full site